Search Login Register
Vestibular Neuronitis
(Vestibular Neuritis)
Summary
Description:
Idiopathic inflammation of the VESTIBULAR NERVE, characterized clinically by the acute or subacute onset of VERTIGO; NAUSEA; and imbalance. The COCHLEAR NERVE is typically spared and HEARING LOSS and TINNITUS do not usually occur. Symptoms usually resolve over a period of days to weeks. (Adams et al., Principles of Neurology, 6th ed, p304)
Also Known As:
Vestibular Neuritis; Acute Peripheral Vestibulopathy; Acute Vestibular Neuritis; Episodic Recurrent Vertigo; Recurrent Vestibular Neuritis Show All >>
Networked: 150
relevant articles (16 outcomes,
12 trials/studies)
for this Disease
Key Drugs and Agents for Vestibular Neuronitis
Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:
-
Adrenal Cortex Hormones (Corticosteroids)
:
6 outcomes 2 studies in 22 results
: IBA
-
Betahistine (Serc)
:
4 outcomes 4 studies in 9 results
: IBA
-
Benign paroxysmal positional vertigo
:
2 outcomes 3 studies in 81 results
: IBA
-
Carbamazepine (Tegretol)
:
2 outcomes 1 study in 5 results
:
FDA 24
Generic
-
Methylprednisolone
:
1 outcome 1 study in 7 results
:
FDA 18
Generic
-
valacyclovir (valaciclovir)
:
1 outcome 1 study in 6 results
:
FDA 12
Generic
-
Cortisone
:
1 outcome 1 study in 4 results
: IBA
-
Dexamethasone (Maxidex)
:
1 outcome 1 study in 3 results
:
FDA 77
Generic
-
Dimenhydrinate (DMH)
:
1 outcome 1 study in 1 result
:
FDA 9
Generic
-
Cinnarizine (Cinna)
:
1 outcome 1 study in 1 result
: IBA
Show All >>
Diseases Related to Vestibular Neuronitis
-
Vertigo (Positional Vertigo)
-
Nausea
-
Meniere Disease (Menieres Disease)
-
Dizziness (Lightheadedness)
-
Bell Palsy (Bell's Palsy)
Show All >>
Key Therapies for Vestibular Neuronitis
Efficacy Chart >>
-
Drug Therapy (Chemotherapy)
:
3 results
-
Hearing Aids (Hearing Aid)
:
1 result
-
Eye Protective Devices (Goggles)
:
1 result
-
Aftercare (After-Treatment)
:
1 result
CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.